Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-25

Clinical Trial Update: Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on transfusion strategies using red blood cells, tranexamic acid, and fibrinogen concentrate for severe trauma at the pre-hospital phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen concentrate (Fibrinogen concentrate)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)
  • red blood cells (red blood cells)

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Polytrauma, Traumatic Hemorrhage | Phase 1, Phase 2 | Status: COMPLETED